Skip to main content
. Author manuscript; available in PMC: 2009 Apr 1.
Published in final edited form as: Nat Clin Pract Endocrinol Metab. 2008 Jun 3;4(7):415–419. doi: 10.1038/ncpendmet0844

Table 1.

The case patient’s laboratory values.

Parameters studied Normal range Results at initial consultation Results after 2 months of anastrozole therapy Results after 5 months of anastrozole therapy
Estradiol (pmol/l; pg/ml) 73–275; 20–75 172; 47 81; 22 <73; <20
Follicle-stimulating hormone (IU/l) 1–14 2 27 34
Luteinizing hormone (IU/l) 1–14 <1 15 9
Total testosterone (nmol/l; ng/dl) 7.7–27.3; 221.8–786.2 5.3; 151.2 16.8; 483.8 14.7; 423.4
Calculated free testosterone (pmol/l; pg/ml) 105–490; 3.0–14.1 102; 2.9 ND ND
Prolactin (pmol; μg/l) 0–609; 0–14 652; 15 ND ND
Insulin-like growth factor I (μg/l) 117–329 102 ND ND
Sex hormone-binding globulin (nmol/l) 13.0–71.0 34.8 ND ND
TSH (mIU/l) 0.4–0.5 3.31 ND ND
Sperm concentration (spermatozoa/ml) <20,000,000 <1,000,000a 15,000,000 21,000,000
a

Seminal fluid analysis was obtained before initial consultation. Abbreviations: ND, not determined; TSH; thyroid-stimulating hormone.

HHS Vulnerability Disclosure